TipRanks
Oncologix Tech Inc (OCLG)
OTHER OTC:OCLG
US Market

Oncologix Tech (OCLG) Ratios

10 Followers

Oncologix Tech Ratios

OCLG's free cash flow for Q1 2023 was $0.00. For the 2023 fiscal year, OCLG's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
Aug 17
Liquidity Ratios
Current Ratio
0.00
Quick Ratio
0.00
Cash Ratio
0.00
Solvency Ratio
0.00
Operating Cash Flow Ratio
0.00
Short-Term Operating Cash Flow Coverage
0.00
Net Current Asset Value
$ 0.00
Leverage Ratios
Debt-to-Assets Ratio
0.00
Debt-to-Equity Ratio
0.00
Debt-to-Capital Ratio
0.00
Long-Term Debt-to-Capital Ratio
0.00
Financial Leverage Ratio
0.00
Debt Service Coverage Ratio
-0.89
Interest Coverage Ratio
-0.69
Debt to Market Cap
0.00
Interest Debt Per Share
<0.01
Net Debt to EBITDA
0.00
Profitability Margins
Gross Profit Margin
20.05%
EBIT Margin
-39.47%
EBITDA Margin
-38.95%
Operating Profit Margin
-30.35%
Pretax Profit Margin
-83.19%
Net Profit Margin
-83.19%
Continuous Operations Profit Margin
-83.19%
Net Income Per EBT
100.00%
EBT Per EBIT
274.10%
Return on Assets (ROA)
0.00%
Return on Equity (ROE)
94.77%
Return on Capital Employed (ROCE)
0.00%
Return on Invested Capital (ROIC)
0.00%
Return on Tangible Assets
0.00%
Earnings Yield
-3218.77%
Efficiency Ratios
Receivables Turnover
0.00
Payables Turnover
0.00
Inventory Turnover
0.00
Fixed Asset Turnover
0.00
Asset Turnover
0.00
Working Capital Turnover Ratio
-0.86
Cash Conversion Cycle
0.00
Days of Sales Outstanding
0.00
Days of Inventory Outstanding
0.00
Days of Payables Outstanding
0.00
Operating Cycle
0.00
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01
Free Cash Flow Per Share
>-0.01
CapEx Per Share
<0.01
Free Cash Flow to Operating Cash Flow
1.04
Dividend Paid and CapEx Coverage Ratio
-26.51
Capital Expenditure Coverage Ratio
-26.51
Operating Cash Flow Coverage Ratio
0.00
Operating Cash Flow to Sales Ratio
>-0.01
Free Cash Flow Yield
-34.10%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.03
Price-to-Sales (P/S) Ratio
0.03
Price-to-Book (P/B) Ratio
0.04
Price-to-Free Cash Flow (P/FCF) Ratio
-2.93
Price-to-Operating Cash Flow Ratio
-3.04
Price-to-Earnings Growth (PEG) Ratio
>-0.01
Enterprise Value Multiple
-0.07
Enterprise Value
73.66K
EV to EBITDA
-0.07
EV to Sales
0.03
EV to Free Cash Flow
-2.93
EV to Operating Cash Flow
-3.04
Tangible Book Value Per Share
0.00
Shareholders’ Equity Per Share
<0.01
Tax and Other Ratios
Effective Tax Rate
>-0.01
Revenue Per Share
<0.01
Net Income Per Share
>-0.01
Tax Burden
1.00
Interest Burden
2.11
Research & Development to Revenue
0.00
SG&A to Revenue
0.50
Stock-Based Compensation to Revenue
0.00
Income Quality
0.01
Currency in USD